8.48
0.17 (2.05%)
| Previous Close | 8.31 |
| Open | 8.18 |
| Volume | 168,921 |
| Avg. Volume (3M) | 189,843 |
| Market Cap | 201,980,016 |
| Price / Sales | 0.610 |
| Price / Book | 1.10 |
| 52 Weeks Range | |
| Earnings Date | 25 Feb 2025 - 3 Mar 2025 |
| Profit Margin | -15.89% |
| Operating Margin (TTM) | -7.90% |
| Diluted EPS (TTM) | -2.25 |
| Quarterly Revenue Growth (YOY) | 5.80% |
| Total Debt/Equity (MRQ) | 10.87% |
| Current Ratio (MRQ) | 2.66 |
| Operating Cash Flow (TTM) | 5.78 M |
| Levered Free Cash Flow (TTM) | 2.52 M |
| Return on Assets (TTM) | -9.66% |
| Return on Equity (TTM) | -25.33% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Inogen, Inc | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -1.5 |
| Technical Oscillators | -0.5 |
| Average | -1.33 |
|
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 1.84% |
| % Held by Institutions | 89.67% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 30 Dec 2024 | Announcement | Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device |
| 07 Nov 2024 | Announcement | Inogen Announces Third Quarter 2024 Financial Results |
| 04 Nov 2024 | Announcement | Inogen to Present at Upcoming Investor Conferences |
| 17 Oct 2024 | Announcement | Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024 |
| 08 Oct 2024 | Announcement | Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |